Psychometric validation of the severity of chronic cough diary, leicester cough questionnaire, and a cough severity visual analogue scale in patients with refractory chronic cough
Findings support the reliability, validity and responsiveness of the newly developed SCCD Cough Frequency and Severity items as fit-for-purpose PRO measures of cough frequency or severity for use in drug development programs within RCC. The LCQ Total, LCQ Physical Domain and Cough Severity VAS also exhibit acceptable measurement properties for use in this population.
Authors
- Claudia Haberland (ORCID: https://orcid.org/0000-0002-5533-1881)
- Adam Gater (ORCID: https://orcid.org/0000-0001-9582-8596)
- Christoph Gerlinger (ORCID: https://orcid.org/0000-0003-4538-6413)
- Nathan A. Clarke (ORCID: https://orcid.org/0000-0002-8636-1872)
- Ulrike Krahn (ORCID: https://orcid.org/0000-0003-4280-9767)
- Andrew Trigg (ORCID: https://orcid.org/0000-0002-1613-8042)
Institutions
- Adelphi Group (United Kingdom) (GB)
- Bayer (Germany) (DE)
- Saarland University (DE)
Publication Details
- Journal
- Journal of Patient-Reported Outcomes
- Published
- 2025-06-11
- DOI
- https://doi.org/10.1186/s41687-025-00888-z
- Citations
- 1
- Primary Topic
- Respiratory and Cough-Related Research
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- Bayer